Transferrin

N/A

Report date: 2023/04/11 20:00:23

Base Information

Drug NameTransferrin
Drug Alias NameOCU-200
ClassificationBiologics > Protein drugs
Mechanisms of ActionAngiogenesis inhibitorsIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOcugen Inc
China Registration ClassN/A

Develop Information

Active CompaniesOcugen Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaWet age-related macular degenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A